<DOC>
	<DOCNO>NCT00295698</DOCNO>
	<brief_summary>The impact lymphatic filariasis ( LF ) HIV assess measure HIV viral load DEC treatment filariasis double-infected individual . The impact HIV lymphatic filariasis assess measure success DEC treatment W. bancrofti antigenaemia microfilaraemia double-infected individual . The effect DEC treatment individual lymphatic filariasis and/or HIV assess measure pre- post-treatment level HIV viral load , immunological response micronutritional parameter , include antioxidant marker oxidative stress , single- double-infected individual . The study carry anonymous , unlinked double-blind placebo control study cross-over design . The study group comprise : 1 ) 18 double-infected individual ( HIV+/LF+ ) , 2 ) 16 HIV infected individual ( HIV+/LF- ) 3 ) 25 individual lymphatic filariasis ( HIV-/LF+ ) . Based stratified , blocked randomisation study participant receive DEC treatment placebo . Pre- post-treatment ( 1 week , 12 week 24 week post-treatment ) blood sample collect analysed HIV viral load , CD4+ T cell count , distinctive Th1 Th2 cytokine , circulate filarial antigen ( CFA ) , micronutrient status , antioxidant enzymes marker oxidative stress . After 12 week study participant get opposite treatment post-treatment blood sample collect four time interval .</brief_summary>
	<brief_title>Interaction Between HIV Lymphatic Filariasis</brief_title>
	<detailed_description>Previous study interaction HIV helminth infection indicate HIV may negative impact helminth infection vice versa , evidence treatment chronic helminth infection HIV infect individual delay progression HIV . These interaction may relate change immunological responsiveness effect reactive oxygen compound result oxidative stress . Oxidative stress may neglect determinant progression lymphatic filariasis may also impair immune function lead increase HIV replication activation nuclear transcription factor . The present study examine three-way interaction HIV infection , lymphatic filariasis cause helminth parasite W. bancrofti drug diethylcarbamazine ( DEC ) . DEC important drug treatment lymphatic filariasis previous finding indicate DEC may also effect retroviral infection . The impact lymphatic filariasis ( LF ) HIV assess measure HIV viral load DEC treatment filariasis double-infected individual . The impact HIV lymphatic filariasis assess measure success DEC treatment W. bancrofti antigenaemia microfilaraemia double-infected individual . The effect DEC treatment individual lymphatic filariasis and/or HIV assess measure pre- post-treatment level HIV viral load , immunological response micronutritional parameter , include antioxidant marker oxidative stress , single- double-infected individual . The study carry anonymous , unlinked double-blind placebo control study cross-over design . The study group comprise : 1 ) 18 double-infected individual ( HIV+/LF+ ) , 2 ) 16 HIV infected individual ( HIV+/LF- ) 3 ) 25 individual lymphatic filariasis ( HIV-/LF+ ) . Based stratified , blocked randomisation study participant receive DEC treatment placebo . Pre- post-treatment ( 1 week , 12 week 24 week post-treatment ) blood sample collect analysed HIV viral load , CD4+ T cell count , distinctive Th1 Th2 cytokine , circulate filarial antigen ( CFA ) , micronutrient status , antioxidant enzymes marker oxidative stress . After 12 week study participant get opposite treatment post-treatment blood sample aree collect four time interval . If treatment coexist helminth infection , include lymphatic filariasis , delay progression HIV , treatment may important measure alleviate effect AIDS epidemic Africa area HIV helminth coexist . For lymphatic filariasis particular information high significance strategic plan decision-makers within ongoing international effort control lymphatic filariasis .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Filariasis</mesh_term>
	<mesh_term>Elephantiasis</mesh_term>
	<mesh_term>Elephantiasis , Filarial</mesh_term>
	<mesh_term>Diethylcarbamazine</mesh_term>
	<criteria>One three follow condition : 1 . Positivity antibody HIV1 HIV2 2 . Positivity circulate filarial antigen W. bancrofti 3 . Positivity HIV antibodies W.bancrofti circulate antigens 1 . AIDS 2 . Hydrocele 3 . Lymphoedema 4 . Elephantiasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>HIV</keyword>
	<keyword>Lymphatic filariasis</keyword>
	<keyword>Diethylcarbamazine</keyword>
	<keyword>Interaction</keyword>
	<keyword>Tanzania</keyword>
</DOC>